However, dysregulation of GAPDH expression in MRONJ in patients with multiple myeloma should be approached with caution, as GAPDH is implicated in multiple cancer-related biological processes, having recently emerged as a primary focus in cancer research [15,16]. This evidence concerns the gene GAPDH and plasma cell myeloma.